XML 34 R8.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:      
Net income (loss) $ (68,445) $ 97,330 $ 29,160
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Loss from discontinued operations, net of tax   273  
Depreciation and amortization 193,138 188,084 174,946
Long-lived and other asset impairment 79,556 44,663 28,127
Goodwill impairment 99,830    
Inventory write-downs 1,349 944 1,614
Amortization of operating lease ROU assets 3,477 2,931  
Amortization of deferred financing costs 5,554 6,211 6,113
Amortization of debt discount 187 910 1,410
Amortization of debt premium (84)    
Amortization of terminated interest rate swaps     291
Debt extinguishment loss 3,971 3,653 2,450
Interest rate swaps 3,178 (1,071) (131)
Stock-based compensation expense 10,551 8,105 7,388
Non-cash restructuring charges 1,660    
Provision for credit losses 3,525 2,567 1,677
(Gain) loss on sale of assets, net 1,832 (16,016) (5,674)
Gain on sale of business (12,475)    
Deferred income tax provision (benefit) (17,764) (39,597) 5,238
Amortization of contract costs 26,629 23,330 14,939
Deferred revenue recognized in earnings (19,489) (42,268) (28,428)
Change in assets and liabilities, net of acquisition:      
Accounts receivable, trade 36,395 3,248 (21,028)
Inventory 3,972 6,036 4,210
Other assets (5,797) 4,458 (15,249)
Contract costs, net (13,262) (27,237) (32,435)
Accounts payable and other liabilities (15,089) (12,728) 14,964
Deferred revenue 12,732 36,578 36,571
Other 147 12 (206)
Net cash provided by continuing operations 335,278 290,416 225,947
Net cash used in discontinued operations   (269)  
Net cash provided by operating activities 335,278 290,147 225,947
Cash flows from investing activities:      
Capital expenditures (140,302) (385,198) (319,102)
Proceeds from sale of business 33,651    
Proceeds from sale of property, plant and equipment and other assets 18,911 80,961 33,927
Proceeds from insurance and other settlements 2,709 3,696 252
Cash paid in Elite Acquisition   (214,019)  
Net cash used in investing activities (85,031) (514,560) (284,923)
Cash flows from financing activities:      
Borrowings of long-term debt 1,049,000 2,395,250 714,830
Repayments of long-term debt (1,204,375) (2,071,750) (605,636)
Payments for debt issuance costs (5,269) (22,426) (3,332)
Proceeds from (payments for) settlement of interest rate swaps that include financing elements (2,916) 1,180 190
Dividends paid to Archrock stockholders (88,832) (78,530) (58,288)
Distributions paid to noncontrolling partners in the Partnership     (11,766)
Proceeds from stock options exercised     264
Proceeds from stock issued under ESPP 683 771 803
Purchases of treasury stock (1,804) (2,007) (1,759)
Contribution from Exterran Corporation 678   18,744
Net cash provided by (used in) financing activities (252,835) 222,488 54,050
Net decrease in cash and cash equivalents (2,588) (1,925) (4,926)
Cash and cash equivalents, beginning of period 3,685 5,610 10,536
Cash and cash equivalents, end of period 1,097 3,685 5,610
Supplemental disclosure of cash flow information:      
Interest paid (99,797) (97,451) (86,758)
Income taxes refunded (paid), net (94) 1,973 2,131
Supplemental disclosure of non-cash investing and financing transactions:      
Accrued capital expenditures 1,624 11,767 17,491
Non-cash consideration received in July 2020 Disposition $ 5,762    
Elite Acquisition      
Supplemental disclosure of non-cash investing and financing transactions:      
Issuance of Archrock common stock pursuant to merger or acquisition, net of tax   $ 225,880  
Merger Transaction      
Supplemental disclosure of non-cash investing and financing transactions:      
Issuance of Archrock common stock pursuant to merger or acquisition, net of tax     $ 57,421